According to the American Academy of Dermatology, vitiligo is considered to be among 24 skin diseases, which are widely prevalent among the population. Vitiligo is known to affect individuals from all ethnic background and genders equivalently. While, vitiligo can affect people from all ages, but the prevalence of the same is more prominent among individuals between the age 10 and 30 years. Moreover, in 2013, it was estimated that more than 150,000 Americans from all age groups underwent treatment for vitiligo. Rising incidences and prevalence of vitiligo is anticipated to further contribute to the growing demand of the global hypopigmentation disorders treatment market.
The Hypopigmentation Disorders Treatment Market is segmented on the basis of Treatment Type, Disease Indication, End Users and region.
Major Treatment Type of Hypopigmentation Disorders Treatment Market covered are:
- Topical Drugs
- Chemical Peels
- Laser Therapy, and Microdermabrasion
Major Disease Indication of Hypopigmentation Disorders Treatment Market covered are:
- Albinism
- Vitiligo
Major End Users of Hypopigmentation Disorders Treatment Market covered are:
- Dermatology Centers
- Aesthetic Clinics
- Hospitals
Since the advent of minimally-invasive procedures, the adoption of such procedures have witnessed substantial growth in recent times. Shorter hospital admittance time, lesser procedure associated pain and fewer complications have been pivotal in contributing to the growing adoption of minimally-invasive procedures. According to the American Society of Plastic Surgeons (ASPS), the numbers of Americans opting for minimally-invasive cosmetic procedures have witnessed a growth of nearly 200% since 2000. In 2017, the total number of cosmetic procedures performed in U.S. was nearly 1.8 million. Growing preference for minimally-invasive cosmetic procedures in anticipated to further propel the growth of the hypopigmentation disorders treatment market.
No comments:
Post a Comment